Glenn, CA
Andrew M. Glenn, Livermore, CA US
Patent application number | Description | Published |
---|---|---|
20130299702 | SYSTEM AND PLASTIC SCINTILLATOR FOR DISCRIMINATION OF THERMAL NEUTRON, FAST NEUTRON, AND GAMMA RADIATION - A scintillator material according to one embodiment includes a polymer matrix; a primary dye in the polymer matrix, the primary dye being a fluorescent dye, the primary dye being present in an amount of 3 wt % or more; and at least one component in the polymer matrix, the component being selected from a group consisting of B, Li, Gd, a B-containing compound, a Li-containing compound and a Gd-containing compound, wherein the scintillator material exhibits an optical response signature for thermal neutrons that is different than an optical response signature for fast neutrons and gamma rays. A system according to one embodiment includes a scintillator material as disclosed herein and a photodetector for detecting the response of the material to fast neutron, thermal neutron and gamma ray irradiation. | 11-14-2013 |
20140027646 | PLASTIC SCINTILLATOR WITH EFFECTIVE PULSE SHAPE DISCRIMINATION FOR NEUTRON AND GAMMA DETECTION - In one embodiment, a scintillator material includes a polymer matrix; and a primary dye in the polymer matrix, the primary dye being a fluorescent dye, the primary dye being present in an amount of 5 wt % or more; wherein the scintillator material exhibits an optical response signature for neutrons that is different than an optical response signature for gamma rays. In another embodiment, a scintillator material includes a polymer matrix; and a primary dye in the polymer matrix, the primary dye being a fluorescent dye, the primary dye being present in an amount greater than 10 wt %. | 01-30-2014 |
20140124677 | MIXED CRYSTAL ORGANIC SCINTILLATORS - A mixed organic crystal according to one embodiment includes a single mixed crystal having two compounds with different bandgap energies, the organic crystal having a physical property of exhibiting a signal response signature for neutrons from a radioactive source, wherein the signal response signature does not include a significantly-delayed luminescence characteristic of neutrons interacting with the organic crystal relative to a luminescence characteristic of gamma rays interacting with the organic crystal. According to one embodiment, an organic crystal includes bibenzyl and stilbene or a stilbene derivative, the organic crystal having a physical property of exhibiting a signal response signature for neutrons from a radioactive source. | 05-08-2014 |
20150028217 | LITHIUM-CONTAINING SCINTILLATORS FOR THERMAL NEUTRON, FAST NEUTRON, AND GAMMA DETECTION - In one embodiment, a scintillator includes a scintillator material; a primary fluor, and a Li-containing compound, where the Li-containing compound is soluble in the primary fluor, and where the scintillator exhibits an optical response signature for thermal neutrons that is different than an optical response signature for fast neutrons and gamma rays. | 01-29-2015 |
Bradley J. Glenn, Danville, CA US
Patent application number | Description | Published |
---|---|---|
20090093765 | Enhanced stability implantable medical device - An implantable medical device is provided which has a housing of an elongate form to minimize a size of an incision required for implantation. A stabilizing element is associated with the elongated form housing for the medical device. The stabilizing element transitions from a low profile initial form to a higher width final form to provide the medical device with a stabilized footprint after implantation. The stabilizing element is in the form of a rotating wing in one embodiment. In another embodiment, the stabilizing element is in the form of an expanding loop that can bend to extend out of side openings of a cavity within the housing, to provide such stabilization at the implantation site. The medical device can be in the form of a pacemaker, infusion pump, vascular access port or other subcutaneously implanted medical device. | 04-09-2009 |
20120197206 | ADHESIVE DRESSING WITH RESEALABLE COVER - A dressing assembly is provided including a cover overlying an inner cavity, spacing portions of the cover away from skin adjacent where the cover is coupled to the skin The cover includes a side wall extending up from a footing surface adapted to be placed adjacent the skin The side wall extends up to a top wall overlying the cavity. A door is provided in the cover through which the inner cavity can be accessed. The door can be sealingly closed and opened to selectively provide access to the cavity or to be closed and maintain a sanitary environment within the cavity. An adhesive membrane is provided adjacent the skin and beneath the footing surface with the adhesive membrane defining a floor of the cavity. A transcutaneous medical device can have portions thereof housed within the cavity where the cover protects it and keeps it sanitary. | 08-02-2012 |
20120265146 | ENHANCED STABILITY IMPLANTABLE MEDICAL DEVICE - An implantable medical device is provided which has a housing of an elongate form to minimize a size of an incision required for implantation. A stabilizing element is associated with the elongated form housing for the medical device. The stabilizing element transitions from a low profile initial form to a higher width final form to provide the medical device with a stabilized footprint after implantation. The stabilizing element is in the form of a rotating wing in one embodiment. In another embodiment, the stabilizing element is in the form of an expanding loop that can bend to extend out of side openings of a cavity within the housing, to provide such stabilization at the implantation site. The medical device can be in the form of a pacemaker, infusion pump, vascular access port or other subcutaneously implanted medical device. | 10-18-2012 |
Bradley J. Glenn, Davis, CA US
Patent application number | Description | Published |
---|---|---|
20100076491 | Intervertebral space implant for use in spinal fusion procedures - An implant assembly is provided for surgical implantation into an intervertebral space, such as for stabilization of vertebrae adjacent the intervertebral space during a spinal fusion procedure. The implant assembly includes a primary segment separate from a secondary segment. These segments are elongate and of sufficiently small cross-section that they can be implanted posteriorly in a minimally invasive manner. The primary segment preferably includes a tunnel and the secondary segment preferably includes a neck with the tunnel and neck sized complementally so that the segments stabilize each other where they intersect with the neck within the tunnel. The entire implant assembly is thus provided which both widens and supports the intervertebral space and is sufficiently rigid to provide adequate support for the intervertebral space as the vertebrae are fusing together. | 03-25-2010 |
Brian Glenn, Plymouth, CA US
Patent application number | Description | Published |
---|---|---|
20110020126 | MODULAR ROTOR BLADE FOR A POWER-GENERATING TURBINE AND A METHOD FOR ASSEMBLING A POWER-GENERATING TURBINE WITH MODULAR ROTOR BLADES - A modular rotor blade for a power generating turbine allows simple replacement of individual rotor blade sections in case of damage to or malfunction of a section. The modular rotor blade includes at least two rotor blade sections, wherein each rotor blade section includes at least one connecting part having at least one conical opening. The connecting parts of adjacent rotor blade sections rest against each other such that the conical openings of the connecting parts are aligned with each other and form a continuous conical connecting opening. Receiving elements for receiving tensioning elements are arranged at the smaller diameter end of the conical connecting opening. A conical bolt corresponding to the continuous conical connecting opening is arranged therein, and at least one tensioning element passes through the conical bolt and tensions the conical bolt against the receiving element. | 01-27-2011 |
20120093627 | METHOD FOR SITE SPECIFIC ENERGY CAPTURE OPTIMIZATION THROUGH MODULAR ROTOR BLADE TIP EXTENSION - A power generating system wherein a turbine ( | 04-19-2012 |
Bryan D. Glenn, Temecula, CA US
Patent application number | Description | Published |
---|---|---|
20140299054 | METHODS AND DEVICES FOR COATING STENTS - Various embodiments of methods and devices for coating stents are described herein. | 10-09-2014 |
David Michael Glenn, Menlo Park, CA US
Patent application number | Description | Published |
---|---|---|
20150121315 | GESTURE BASED METHOD FOR ENTERING MULTI-VARIABLE DATA ON A GRAPHICAL USER INTERFACE. - A gesture based method for entering multi-dimensional data on a graphical user interface, for use in conjunction with a portable electronic device with a touch screen display, comprising a plurality of vertical and horizontal gestures to specify two different but logically related items of data. | 04-30-2015 |
20150142470 | GRAPHICAL USER INTERFACE APPARATUS FOR SEARCHING AND DISPLAYING MEDICAL CODES IN AN ELECTRONIC ANESTHESIA RECORD - An apparatus for improved searching and selecting of medical coding information for an electronic anesthesia record on a multi-function gesture-sensitive device. | 05-21-2015 |
20150150519 | APPARATUS AND METHODS FOR MANAGING BLOOD PRESSURE VITAL SIGN CONTENT IN AN ELECTRONIC ANESTHESIA RECORD. - A graphical user interface and methods for managing blood pressure vital sign content in an electronic anesthesia record on a multi-function gesture-sensitive device via gesture-based means. The graphical user interface and methods give an improved user interface and set of functions via novel functions unique to gesture sensitive interfaces. | 06-04-2015 |
20160070872 | APPARATUS AND METHODS FOR MANAGING MEDICATION DOSING CONTENT IN AN ELECTRONIC ANESTHESIA RECORD - An apparatus and method for managing medications via gesture-based means in an electronic anesthesia record on a multi-functional device with a gesture-sensitive interface. | 03-10-2016 |
Everett Glenn, Long Beach, CA US
Patent application number | Description | Published |
---|---|---|
20150081532 | VENUE WI-FI DIRECT SYSTEM - The embodiments disclose a method including providing venue specific localized WI-FI user mobile venue related services in a covered venue area, installing in a densely populated covered venue area technology capabilities capable of handling a number of users in real time and a number of services in real-time, and using localized WI-FI user mobile applications to provide venue related services. | 03-19-2015 |
Gregory J. Glenn, Irving, CA US
Patent application number | Description | Published |
---|---|---|
20160114115 | VENTILATION TRIGGERING - The systems and methods provide for novel a triggering mode that allows the patient to trigger or initiate the delivery of a breath during ventilation on a ventilator. Further, the systems and methods provide for triggering ventilation utilizing a statistical trigger mode. Additionally, the systems and methods provide for analyzing and/or displaying information related to a potential change in a triggering threshold for a currently utilized breath type. | 04-28-2016 |
Jeffrey Glenn, Palo Alto, CA US
Patent application number | Description | Published |
---|---|---|
20080261906 | METHODS AND COMPOSITIONS FOR IDENTIFYING ANTI-HCV AGENTS - The invention features methods and compositions for screening for agents that modulate replication of a virus, particularly Flaviviridae virus (particularly hepatitis C virus (HCV)), where the methods provide for detection of agents that modulate the binding of TBC and NS5A, the inhibition of TBC activity, inhibition of Rab1 activity, and/or the expression of the TBC protein and/or Rab1 protein. The invention also features methods of controlling viral replication, and agents useful in such methods. | 10-23-2008 |
20090105151 | AMPHIPATHIC ALPHA-HELICAL PEPTIDE COMPOSITIONS AS ANTIVIRAL AGENTS - The invention features methods and compositions that exploit the ability of amphipathic alpha-helical (AH) peptides to cause disruption of lipid-containing vesicles, such as enveloped viruses, in a size-dependent manner. | 04-23-2009 |
Jeffrey S. Glenn, Palo Alto, CA US
Patent application number | Description | Published |
---|---|---|
20080214471 | Method for inhibition of viral infection - The invention is directed to inhibiting viral morphogenesis and viral infection. In particular, it concerns effecting such inhibition by inhibiting the prenylation or post prenylation reactions of a viral or host protein. | 09-04-2008 |
20090083869 | METHODS AND COMPOSITIONS FOR IDENTIFYING AGENTS THAT INHIBIT AN NS4B-MEDIATED NEOPLASTIC CELLULAR PHENOTYPE OF HCV INFECTED CELLS - The disclosure provides methods and compositions for identifying agents that inhibit a neoplastic cellular phenotype mediated by the NS4B protein nucleotide binding motif (NBM) of hepatitis C virus (HCV). In general, the methods involve contacting a candidate agent with a mammalian cell expressing an NS4B NBM polypeptide of an HCV virus, wherein expression of the NS4B NBM polypeptide in the absence of candidate agent promotes a neoplastic cellular phenotype, and detecting the presence or absence of an effect of said candidate agent on NS4B-mediated promotion of a neoplastic cellular phenotype. The disclosed methods and compositions find use in a variety of therapeutic and screening applications. | 03-26-2009 |
20100015093 | Methods and compositions of treating a flaviviridae family viral infection - Briefly described, embodiments of this disclosure include compounds, pharmaceutical compositions, methods of treating a host infected with a virus from the Flaviviridae family of viruses, methods of inhibiting HCV replication in a host, methods of inhibiting the binding of NS4B polypeptide to the 3′UTR of HCV negative strand RNA in a host, methods of treating liver fibrosis in a host, and the like. | 01-21-2010 |
20100028299 | Methods and compositions of treating a flaviviridae family viral infection - Briefly described, embodiments of this disclosure include compounds, pharmaceutical compositions, methods of treating a host infected with a virus from the Flaviviridae family of viruses, methods of inhibiting HCV replication in a host, methods of inhibiting the binding of NS4B polypeptide to the 3′UTR of HCV negative strand RNA in a host, methods of treating liver fibrosis in a host, and the like. | 02-04-2010 |
20100203498 | METHODS AND COMPOSITIONS FOR IDENTIFYING ANTI-HCV AGENTS - The invention provides methods and compositions for identifying agents for treating infection by viruses that encode a nucleotide-binding NS4B protein, or functional equivalent thereof, e.g., hepatitis C virus (HCV) or other members of the family Flaviviridae. In general, the methods involve contacting an NS4B nucleotide binding motif (NBM)-containing polypeptide with a candidate agent, and determining the effect of the candidate agent on nucleotide binding activity, a nucleotide hydrolyzing activity, or a nucleotide-dependent RNA binding activity of the polypeptide. A candidate agent that inhibits NS4B polypeptide binding to a nucleotide is an anti-viral agent, e.g., an anti-HCV agent. The invention also features a polynucleotide encoding a NS4B polypeptide having a modified NBM (e.g., which is impaired in NTP binding). The subject methods and compositions find use in a variety of therapeutic and screening applications. | 08-12-2010 |
20100260717 | METHODS OF TREATING A FLAVIVIRIDAE FAMILY VIRAL INFECTION, COMPOSITIONS FOR TREATING A FLAVIVIRIDAE FAMILY VIRAL INFECTION, AND SCREENING ASSAYS FOR IDENTIFYING COMPOSITIONS FOR TREATING A FLAVIVIRIDAE FAMILY VIRAL INFECTION - Briefly described, embodiments of this disclosure include compositions, pharmaceutical compositions, methods of treating a host infected with a virus from the Flaviviridae family of viruses, methods of identifying a candidate agent for the treatment of hepatitis C virus (HCV) infection, and the like. | 10-14-2010 |
20110052536 | METHODS OF TREATING A FLAVIVIRIDAE FAMILY VIRAL INFECTION AND COMPOSITIONS FOR TREATING A FLAVIVIRIDAE FAMILY VIRAL INFECTION - Briefly described, embodiments of this disclosure include compositions, pharmaceutical compositions, methods of treating a host infected with a virus from the Flaviviridae family of viruses, methods of treating HCV replication in a host, methods of inhibiting the binding of NS4B polypeptide to the 3′UTR of HCV negative strand RNA in a host, methods of treating liver fibrosis in a host, and the like. | 03-03-2011 |
20110217265 | Screening for Inhibitors of HCV Amphipathic Helix (AH) Function - Screening methods are provided for identifying pharmacologic inhibitors of HCV amphipathic helix (AH) function, which inhibitors are useful in the prevention and treatment of HCV infection. Also provided are compounds useful in the inhibition of viral replication. The methods of the invention are based on the unexpected discovery that the presence of an AH, e.g. an AH of an HCV polypeptide, causes an increase in the apparent diameter of the vesicles. The methods of the invention provide for addition of AH peptides to lipid vesicles, for example in a high-throughput format; which addition may be performed in the absence or presence of a candidate pharmacologic agent. The change in apparent vesicle size is measured, and compared to control samples. An increase in vesicle size or aggregation is indicative of AH function being present; and a lack of increase is indicative that the AH function is absent or has been inhibited by a test agent. | 09-08-2011 |
20110256183 | Hydrogels with network defects enhanced by nanoparticle incorporation - Compositions and methods are provided for the manufacture and use of hydrogels with increased permeability to macromolecules with minimum loss of matrix mechanical strength and prepolymer viscosity for patternability. The hydrogels of the invention are formed from a prepolymer, which is polymerized in the presence of hydrophobic nanoparticles. In some embodiments of the invention cells are present during polymerization, and are encapsulated by the hydrogel. A high interfacial energy between the hydrophobic substrate and the aqueous polymerizing solution disrupts the hydrogel network structure, leading to network defects that increase permeability without loss of patternability. | 10-20-2011 |
20110262565 | PIP-2 Inhibition-Based Antiviral and Anti-Hyperlipidemic Therapies - Interaction of a specific viral domain with phosphatidylinositol 4,5-bisphosphate (PIP 2) is shown to mediate viral replication. Basic Amino Acid PIP-2 Pincer (BAAPP) domains are described herein, including, without limitation, NS5A protein of HCV, NS4B protein of HCV, poliovirus, and rhinovirus. | 10-27-2011 |
20120093849 | Agents for Treatment of HCV and Methods of Use - An amphipathic helix at the approximate N-terminus of Hepatitis C virus (HCV) nonstructural proteins mediates the association of these proteins with cytoplasmic membranes in infected cells. This association is essential for replication. Thus, assessing the ability of compounds or protocols to disrupt the association of such helices with cytoplasmic membranes permits identification of compounds and protocols which are useful in the treatment of HCV infection. Also useful in the invention are mimics, or function-disrupting ligands, of an amphipathic helix of the nonstructural proteins described herein and antibodies and fragments thereof immunoreactive with said helix. | 04-19-2012 |
20120148534 | METHODS AND COMPOSITIONS OF TREATING A FLAVIVIRIDAE FAMILY VIRAL INFECTION - Briefly described, embodiments of this disclosure include compounds, pharmaceutical compositions, methods of treating a host infected with a virus from the Flaviviridae family of viruses, methods of inhibiting HCV replication in a host, methods of inhibiting the binding of NS4B polypeptide to the 3′UTR of HCV negative strand RNA in a host, methods of treating liver fibrosis in a host, and the like. | 06-14-2012 |
20120276050 | METHODS AND COMPOSITIONS OF TREATING A FLAVIVIRIDAE FAMILY VIRAL INFECTION - Clemizole and clemizole analog compounds, and pharmaceutical compositions of the same, are useful in methods of treating a host infected with a virus from the Flaviviridae family of viruses, methods of inhibiting HCV replication in a host, methods of inhibiting the binding of NS4B polypeptide to the 3′UTR of HCV negative strand RNA in a host, and methods of treating liver fibrosis in a host. | 11-01-2012 |
20130288917 | Rapid High Resolution, High Throughput RNA Structure, RNA-Macromolecular Interaction, and RNA-Small Molecule Interaction Mapping - Compositions and methods are provided for a rapid, high-resolution, high-throughput method for determining the intramolecular interactions between the nucleotides present in an polynucleotide, such that single-stranded nucleotides, and nucleotides in a double-stranded configuration are distinguished and identified. Tertiary contacts and solvent accessible regions may also be determined, where such contacts and regions may result from a single stranded configuration, intermolecular interactions with other macromolecules including, without limitation, DNA, protein, RNA, etc.; intermolecular interactions with small molecules which may include drug candidates; or a combination of macromolecules and small molecules. | 10-31-2013 |
20150044169 | METHODS OF TREATING A FLAVIVIRIDAE FAMILY VIRAL INFECTION, COMPOSITIONS FOR TREATING A FLAVIVIRIDAE FAMILY VIRAL INFECTION, AND SCREENING ASSAYS FOR IDENTIFYING COMPOSITIONS FOR TREATING A FLAVIVIRIDAE FAMILY VIRAL INFECTION - Briefly described, embodiments of this disclosure include compositions, pharmaceutical compositions, methods of treating a host infected with a virus from the Flaviviridae family of viruses, methods of identifying a candidate agent for the treatment of hepatitis C virus (HCV) infection, and the like. | 02-12-2015 |
20150051193 | PI-kinase Inhibitors with Broad Spectrum Anti-Infective Activity - Compounds and methods are provided for the treatment of pathogen infections. In some embodiments, the anti-infective compounds have broad spectrum activity against a variety of infective diseases, where the diseases are caused by pathogens containing a basic amino acid PIP-2 pincer (BAAPP) domain that interacts with phosphatidylinositol 4,5-bisphosphate (PIP-2) to mediate pathogen replication. Also provided are methods of inhibiting a PI4-kinase and methods of inhibiting viral infection. In some embodiments, the compound is a PI4-kinase inhibiting compound that is a 5-aryl-thiazole. The subject compounds may be formulated or provided to a subject in combination with a second anti-infective agent, e.g. interferon, ribivarin, and the like. | 02-19-2015 |
20150152064 | METHODS AND COMPOSITIONS OF TREATING A FLAVIVIRIDAE FAMILY VIRAL INFECTION - Briefly described, embodiments of this disclosure include compounds, pharmaceutical compositions, methods of treating a host infected with a virus from the Flaviviridae family of viruses, methods of inhibiting HCV replication in a host, methods of inhibiting the binding of NS4B polypeptide to the 3′UTR of HCV negative strand RNA in a host, methods of treating liver fibrosis in a host, and the like. | 06-04-2015 |
20160113919 | CHLOROQUINE STEREOISOMER FOR TREATING TUBERCULOSIS RELATED DISEASES - This disclosure provides a method of treating a subject infected with a mycobacteria of the | 04-28-2016 |
Jonathan P. Glenn, Los Angeles, CA US
Patent application number | Description | Published |
---|---|---|
20090211860 | WIRE AND CABLE ORGANIZING SYSTEM - A simple and effective wire and cable management device includes a housing generally in the form of a rectangular cuboid having opposing front and back walls, opposing top and bottom walls and opposing first and second side walls. A reel is disposed within the housing and is rotatable on an axis perpendicular to the front and back walls. A peripheral portion of the reel extends through an opening in the side wall of the housing. At least two of the opposing walls have cooperating mechanical couplings for securing the device to another identical device so that a plurality of devices may be easily connected together to manage and organize an array of wires, cables and cords. | 08-27-2009 |
Julia B. Glenn, Fairfield, CA US
Patent application number | Description | Published |
---|---|---|
20140312049 | Wedged Tissue and/or Wet Wipe Dispenser - A wedged dispenser for provisioning tissues and/or wet wipes. The wedged dispenser has a tapered retention wall and a dispensing panel that delineate an interior storage volume. A terminal end of the tapered retention wall allows the wedged dispenser to be utilized in tight, limited space areas, while a widened end opposite the terminal end allows for a larger surface area from which tissues and/or wet wipes are dispensed. The dispensing panel is positioned across the widened end, with a panel opening traversing through the dispensing panel. The panel opening provides access to the interior storage volume and allows tissues and/or wet wipes to be readily dispensed through the dispensing panel. Depending on the desired material to be stored within the interior storage volume, the wedged dispenser is outfitted with either a flexible cover or a lid assembly having a self-contained storage bag, which is positioned about the panel opening. | 10-23-2014 |
Matthew Glenn, San Francisco, CA US
Patent application number | Description | Published |
---|---|---|
20090119762 | WLAN Access Integration with Physical Access Control System - A network access system. In particular implementations, a method includes monitoring, responsive to a network access request of a client, an authentication session between an authentication server and the client, and determining user credential information associated with a user of the client based on one or more messages of the authentication session. The method also includes accessing, using the user credential information, physical entry information indicating a physical location of the user relative to a defined perimeter, and conditionally allowing the client access to a network based on the physical entry information and a successful authentication of the client. | 05-07-2009 |
Matthew K. Glenn, Mountain View, CA US
Patent application number | Description | Published |
---|---|---|
20140310408 | HANDLING CHANGES IN A DISTRIBUTED NETWORK MANAGEMENT SYSTEM THAT USES A LOGICAL MULTI-DIMENSIONAL LABEL-BASED POLICY MODEL - A change to a state of a particular managed server within an administrative domain is processed. The administrative domain includes a plurality of managed servers that use management instructions to configure management modules so that the configured management modules implement an administrative domain-wide management policy that comprises a set of one or more rules. A first description of the particular managed server is modified to indicate the particular managed server's changed state, thereby specifying a second description of the particular managed server. The unmodified first description is compared to the second description, thereby specifying a description change. A determination is made, based on the description change, regarding whether to update management instructions previously sent to the particular managed server. | 10-16-2014 |
20140310415 | DISTRIBUTED NETWORK MANAGEMENT USING A LOGICAL MULTI-DIMENSIONAL LABEL-BASED POLICY MODEL - Management instructions for a particular managed server within an administrative domain are generated according to an administrative domain-wide management policy that comprises a set of one or more rules. The administrative domain includes a plurality of managed servers. A determination is made regarding which rules within the set of rules are relevant to the particular managed server. Function-level instructions are generated based on the rules that were determined to be relevant. A determination is made regarding which managed servers within the plurality of managed servers are relevant to the particular managed server. The function-level instructions and information regarding the managed servers that were determined to be relevant are sent to the particular managed server. The particular managed server uses the function-level instructions and information regarding the managed servers to configure a management module so that the configured management module implements the administrative domain-wide management policy. | 10-16-2014 |
20140373091 | Distributed Network Security Using a Logical Multi-Dimensional Label-Based Policy Model - A managed server (MS) within an administrative domain is quarantined. The administrative domain includes multiple MSs that use management instructions to configure management modules so that the configured management modules implement an administrative domain-wide management policy that comprises a set of one or more rules. The quarantined MS is isolated from other MSs. A description of the MS is modified to indicate that the MS is quarantined, thereby specifying a description of the quarantined MS. Cached actor-sets are updated to indicate the quarantined MS's changed state, thereby specifying updated actor-sets. A determination is made regarding which updated actor-sets are relevant to an other MS, thereby specifying currently-relevant updated actor-sets. A determination is made regarding whether the currently-relevant updated actor-sets differ from actor-sets previously sent to the other MS. Responsive to determining that the currently-relevant updated actor-sets are identical to the previously-sent actor-sets, no further action is taken. | 12-18-2014 |
20150127832 | Pairing in a Distributed Network Management System that Uses a Logical Multi-Dimensional Label-Based Policy Model - A server is paired. A pairing request that includes a pairing key is received from an unpaired server. A determination is made regarding whether to approve or reject the pairing request. Making the determination comprises attempting to validate the pairing key in the pairing request. Responsive to determining to approve the pairing request: the unpaired server is notified that the unpaired server is now a managed server; a description of the managed server is generated, wherein the managed server description includes a set of one or more labels that describe the managed server; management instructions are generated for the managed server based on the managed server description and based on an administrative domain-wide management policy that includes a rule that refers to managed servers using a label; and the management instructions are sent to the managed server. | 05-07-2015 |
20150128211 | AUTOMATED GENERATION OF ACCESS CONTROL RULES FOR USE IN A DISTRIBUTED NETWORK MANAGEMENT SYSTEM THAT USES A LABEL-BASED POLICY MODEL - An access control rule authorizing communication between a plurality of managed servers within an administrative domain is determined. Communication information describing past communication between the plurality of managed servers is obtained. A subset of managed servers from the plurality of managed servers is identified by grouping the plurality of managed servers based on the obtained communication information. A group-level label set is determined to associate with the subset of managed servers. Role labels are determined for managed servers in the subset of managed servers. A managed server is associated with one role label. Based on the group-level label set and the role labels, an access control rule is generated authorizing communication between a first managed server of the subset of managed servers and a second managed server. The access control rule is stored as part of an administrative domain-wide management policy. | 05-07-2015 |
Michael Glenn, Orange, CA US
Patent application number | Description | Published |
---|---|---|
20130220885 | PROCESS FOR HYDROCRACKING A HYDROCARBON FEEDSTOCK - A hydrocracking process comprising the steps of: (a) combining a hydrocarbonaceous feedstock and a heavy bottom fraction recycle stream with a hydrogen-rich gas to obtain a mixture comprising hydrocarbonaceous feedstock and hydrogen; (b) catalytically hydrocracking the mixture comprising hydrocarbonaceous feedstock and hydrogen in a hydrocracking zone to obtain a hydrocracked effluent; (c) separating the hydrocracked effluent into a first vapour portion and a first liquid portion in a separation zone; (d) heating the first liquid portion to form a vapourised first liquid portion; (e) feeding the vapourised first liquid portion to a fractionation section producing individual product fractions including a heavy bottom fraction comprising unconverted oil at the bottom zone of the fractionation section; (f) withdrawing from the fractionation section the heavy bottom fraction; (g) splitting the heavy bottom fraction in a stream for stripping and a heavy bottom fraction recycle stream; (h) stripping the stream for stripping, with a stripping medium, in a counter current stripping column to form an overhead vapour and a stripped liquid; (i) feeding the overhead vapour to the fractionation section, to a recycle stream or to a position upstream the fractionation section; and (j) removing at least a part of the stripped liquid from the counter current stripping column as a net purge of unconverted oil. | 08-29-2013 |
Patrick Kenneth Glenn, Torrance, CA US
Patent application number | Description | Published |
---|---|---|
20130275334 | SYSTEM AND METHOD FOR MANAGING ASSET PORTFOLIOS - In exemplary embodiments of a computer implemented method, system and computer program for managing asset portfolios, asset allocation results conventionally dictated by Modern Portfolio Theory are modified through implementation of at least a market timing enhancement which signals when an investor should exit individual declining investment portfolio components. By optimizing an oscillator averaging period, computing an oscillator time history and optimizing long and short margin percentages of each of a defined portfolio of investment components, a modified time history of total return for each component is calculated. After inputting the modified time histories into a Classic Modern Portfolio Theory algorithm, allocations are altered based in the current value of the oscillator. | 10-17-2013 |
Richard Glenn, Santa Rosa, CA US
Patent application number | Description | Published |
---|---|---|
20110112548 | METHODS AND SYSTEMS FOR REMOVAL OF IMPLANTABLE INTRAVASCULAR DEVICES - Improved methods, systems and apparatuses for extracting devices implanted within the vasculature of a patient are provided, including a method of extracting an intravascular device anchored in a vasculature of a patient, the device including a device body and a lead coupled to the device body, the lead having a distal end including an electrode, the distal end being fixed in a heart of the patient, the method comprising forming an incision in the vasculature, disconnecting the lead from the device body, removing the distal end of the lead from the heart, withdrawing the lead from the patient, disconnecting the device body from an anchor, and withdrawing the device body from the patient via the incision. | 05-12-2011 |
20160038285 | SYSTEMS AND METHODS FOR RESHAPING A HEART VALVE - The present disclosure includes a device for reshaping a heart valve. The device may include a central ring about a central axis and a plurality of arms coupled to the central ring, each of the arms coupled to the central ring at a pivot point at a first end of the arm, the arm comprising an attachment feature at a second point along the arm, the pivot point configured to allow movement of the arm about the pivot point through a plane extending radially from the central axis through the arm. Additionally, the plurality of arms may be contractable and may be extendable such that the hooks extend beyond a dilated heart valve. The present disclosure also includes associated methods and systems. | 02-11-2016 |
20160113799 | SATIATION DEVICES AND METHODS - A device for inducing weight loss in a patient includes a tubular prosthesis self-expandable from a collapsed position in which the prosthesis has a first diameter to an expanded position in which the prosthesis has a second, larger, diameter. In a method for inducing weight loss, the prosthesis is placed in the collapsed position and inserted into a stomach of a patient. The prosthesis is allowed to self-expand from the collapsed position to the expanded position and into contact with the walls of the stomach, where it induces feelings of satiety and/or inhibits modulation of satiety-controlling factors such as Ghrelin. | 04-28-2016 |
Tracey Glenn, Altadena, CA US
Patent application number | Description | Published |
---|---|---|
20110259775 | LABELS, RELATED PADS THEREOF, AND RELATED METHODS - A label is provided that includes a body portion having an area, a front surface, and a back surface. The label also includes a tab portion having an area and a back surface, and the tab portion is integrally coupled to the body portion and extending from an end of the body portion. A line of weakness divides the tab portion and the body portion, and the line of weakness is formed such that the tab portion is selectively separable form the body portion along the line of weakness. A layer of adhesive is provided on the back surface of the body portion of the label, and a majority of the back surface of the tab portion is free of adhesive. The area of the tab portion is less than the area of the body portion. | 10-27-2011 |
20130221651 | LABELS, RELATED PADS THEREOF, AND RELATED METHODS - A pad is provided that includes a plurality of labels each including a body portion having an area, a front surface, and a back surface. Each of the plurality of labels also includes a tab portion having an area less than the area of the body portion, and a back surface that is integrally coupled to and extending from an end of the body portion. A line of weakness divides the tab portion and the body portion, and allows the tab portion to be selectively separable from the body portion along the line of weakness. A layer of adhesive is provided on the back surface of the body portion where the majority of the back surface of the tab portion is free of adhesive, and the plurality of labels are stacked such that an overlying label is releasably adhered to the front surface of an adjacent underlying label via the adhesive layer. | 08-29-2013 |
Walter B. Glenn, Pacifica, CA US
Patent application number | Description | Published |
---|---|---|
20090214786 | MULTI-STATION DEPOSITION APPARATUS AND METHOD - A multi-station deposition apparatus capable of simultaneous processing multiple substrates using a plurality of stations, where a gas curtain separates the stations. The apparatus further comprises a multi-station platen that supports a plurality of wafers and rotates the wafers into specific deposition positions at which deposition gases are supplied to the wafers. The deposition gases may be supplied to the wafer through single zone or multi-zone gas dispensing nozzles. | 08-27-2009 |
20100316800 | MULTI-STATION DEPOSITION APPARATUS AND METHOD - A multi-station deposition apparatus capable of simultaneous processing multiple substrates using a plurality of stations, where a gas curtain separates the stations. The apparatus further comprises a multi-station platen that supports a plurality of wafers and rotates the wafers into specific deposition positions at which deposition gases are supplied to the wafers. The deposition gases may be supplied to the wafer through single zone or multi-zone gas dispensing nozzles. | 12-16-2010 |
Walter Benjamin Glenn, Pacifica, CA US
Patent application number | Description | Published |
---|---|---|
20090056626 | APPARATUS FOR CYCLICAL DEPOSITING OF THIN FILMS - An apparatus for cyclical depositing of thin films on semiconductor substrates, comprising a process chamber having a gas distribution system with separate paths for process gases and an exhaust system synchronized with operation of valves dosing the process gases into a reaction region of the chamber. | 03-05-2009 |